Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | NR2E3 | Q9Y5X4 | 2/20 | 0.39 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 6/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.37 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13642789 | 0.83 | ALDH1A1 (0.42) | TSHRALDH1A1PRKCA | |
| SCHEMBL12695919 | 0.81 | ALDH1A1 (0.66) | TDP1PTGER2TSHRALDH1A1PRKCA | |
| SCHEMBL20251162 | 0.80 | ALDH1A1 (0.49) | TSHRALDH1A1 | |
| SCHEMBL20251160 | 0.80 | ALDH1A1 (0.49) | TSHRALDH1A1 | |
| SCHEMBL16522363 | 0.80 | ALDH1A1 (0.49) | TSHRALDH1A1 | |
| SCHEMBL20251191 | 0.80 | ALDH1A1 (0.49) | TSHRALDH1A1 | |
| SCHEMBL15095421 | 0.79 | ALDH1A1 (0.46) | TSHRALDH1A1 | |
| Acetone SCHEMBL29197565 | 0.77 | ALDH1A1 (0.56) | TSHRALDH1A1PPARGPRKCA | |
| SCHEMBL1094586 | 0.76 | ALDH1A1 (0.62) | TSHRALDH1A1PPARGL3MBTL1PRKCA | |
| SCHEMBL4612541 | 0.76 | ALDH1A1 (0.62) | TSHRALDH1A1PPARGL3MBTL1PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120283156-A1 | FUNCTIONALIZED MONOMERS | ELEVANCE RENEWABLE SCIENCES | 2012-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283156-A1 | FUNCTIONALIZED MONOMERS | MEP1A, MLEC, ELANE | TDP1 3103/4885PTGER2 1362/4885TSHR 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.